Overview
Chang-bae Kong practices practicing medicine in Seoul, Republic of Korea.
Kong is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Osteosarcoma, Adult Soft Tissue Sarcoma, and Bone Tumor.
They are actively involved in clinical research, co-authoring 42 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chang-bae Kong
Is Chang-bae Kong a top-rated expert for Osteosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Chang-bae Kong is classified as an Elite expert for Osteosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chang-bae Kong participate in research or clinical trials?
Yes. Chang-bae Kong has published 42 articles and abstracts on conditions like Osteosarcoma. You can view a list of Chang-bae Kong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- OsteosarcomaKong isElite. Learn about Osteosarcoma.
- Distinguished
- Adult Soft Tissue SarcomaKong isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Advanced
- Bone TumorKong isAdvanced. Learn about Bone Tumor.